<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04862754</url>
  </required_header>
  <id_info>
    <org_study_id>P.T REC/017/00497.</org_study_id>
    <nct_id>NCT04862754</nct_id>
  </id_info>
  <brief_title>Effect of Interval Training on Arterial Stiffness in Women With Hypertension</brief_title>
  <official_title>Effect of Interval Training on Arterial Stiffness in Women With Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      this study is aiming to assess the chronic effect of the interval training program on&#xD;
      arterial stiffness in women with hypertension&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 25, 2021</start_date>
  <completion_date type="Actual">April 15, 2021</completion_date>
  <primary_completion_date type="Actual">March 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Central arterial stiffness measurements (Pulse Wave Velocity [PWV], augmentation index )</measure>
    <time_frame>two months</time_frame>
    <description>Pulse wave analysis (PWA) of the women in the two groups: pre and post treatment for pulse wave velocity (PWV) and augmentation index(AIx)&#xD;
Pulse Wave Velocity [PWV], augmentation index (AIx @75HR) and resting heart rate were measured using analysis equipment which called Non-invasive blood pressure measurement system using &quot;Mobil-O-Graph 24h PWA &quot; with Hypertension Management Software Client Server (HMS-CS 4.3). PWA was performed using an oscillometric Mobil-O-Graph R 24 h PWA Monitor device (I.E.M GmbH, Germany) with integrated ARCSolver® software</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood lipid profile</measure>
    <time_frame>two months</time_frame>
    <description>blood analysis will be used to measure lipid profile (high and low-density lipoprotein, cholesterol, triglyceride)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>interleukin 6</measure>
    <time_frame>two months</time_frame>
    <description>blood analysis will be used to measure interleukin 6</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood pressure (systolic and diastolic)</measure>
    <time_frame>two months</time_frame>
    <description>resting Blood pressure was monitored from the right arm using an automated digital electronic BP monitor (Omron digital BP monitor, Model 11 EM 403c; Tokyo Japan).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Arterial Stiffness</condition>
  <arm_group>
    <arm_group_label>interval training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Aerobic interval training. It consisted of a modified interval cycle ergometer training program (3 days a week for 8 weeks). AIT consisted of 8 min warm up, followed by four times of 4-min intervals with HR at 80% of submaximal predetermined HR, with active phases of 3 min of cycling at 60% of submaximal predetermined HR. The exercise session was terminated by 5 min cool down</description>
  </arm_group>
  <arm_group>
    <arm_group_label>medical treatment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>hypertensive medication</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>interval training exercise</intervention_name>
    <description>interval training exercise</description>
    <arm_group_label>interval training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  physically inactive&#xD;
&#xD;
          -  BMI 30-40&#xD;
&#xD;
          -  Stage 1 and 2 hypertension&#xD;
&#xD;
          -  Elevated BP as systolic BP ≥130 mm Hg and/or diastolic BP ≥85 mm Hg measured at the&#xD;
             brachial artery.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Medications known to affect weight or appetite&#xD;
&#xD;
          -  Any disease associated with exercise intolerance.&#xD;
&#xD;
          -  Women were taking hormone replacement therapy&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Faculty of physical therapy</name>
      <address>
        <city>Cairo</city>
        <zip>17452</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>January 12, 2021</study_first_submitted>
  <study_first_submitted_qc>April 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2021</study_first_posted>
  <last_update_submitted>April 23, 2021</last_update_submitted>
  <last_update_submitted_qc>April 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Mona Mohamed Taha</investigator_full_name>
    <investigator_title>Cairo University</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

